Plasma Therapy Market
Plasma Therapy Market - Global Industry Assessment & Forecast
Segments Covered
- By Type Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin, Hyperbaric Oxygen Therapy (HBOT), Combined Plasma Therapy with Stem Cells, Other Types
- By Source Autologous, Allogenic
- By Application Orthopedics, Dermatology, Hematology, Neurology, Immunology, Dental, Other Applications
- By End User Hospitals, Clinics, Ambulatory Surgical Centers, Research Institutes, Other End-Users
- By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa, Latin America
Snapshot
Base Year: | 2022 |
Forecast Years: | 2023 - 2030 |
Historical Years: | 2017 - 2021 |
Revenue 2022: | USD 359.8 Billion |
Revenue 2030: | USD 653.5 Billion |
Revenue CAGR (2023 - 2030): | 13.9% |
Fastest Growing Region (2023 - 2030) | Asia Pacific |
Largest Region (2022): | North America |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
Plasma Therapy Market Segment Analysis
- Plasma Therapy Type Outlook (Revenue, USD Million, 2018 - 2030)
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
- Hyperbaric Oxygen Therapy (HBOT)
- Combined Plasma Therapy with Stem Cells
- Other Types
- Plasma Therapy Source Outlook (Revenue, USD Million, 2018 - 2030)
- Autologous
- Allogenic
- Plasma Therapy Application Outlook (Revenue, USD Million, 2018 - 2030)
- Orthopedics
- Dermatology
- Hematology
- Neurology
- Immunology
- Dental
- Other Applications
- Plasma Therapy End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Other End-Users
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Plasma Therapy Market, by Type
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
- Hyperbaric Oxygen Therapy (HBOT)
- Combined Plasma Therapy with Stem Cells
- Other Types
-
North America Plasma Therapy Market, by Source
- Autologous
- Allogenic
-
North America Plasma Therapy Market, by Application
- Orthopedics
- Dermatology
- Hematology
- Neurology
- Immunology
- Dental
- Other Applications
-
North America Plasma Therapy Market, by End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Other End-Users
- U.S.
- U.S. Plasma Therapy Market, by Type
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
- Hyperbaric Oxygen Therapy (HBOT)
- Combined Plasma Therapy with Stem Cells
- Other Types
- U.S. Plasma Therapy Market, by Source
- Autologous
- Allogenic
- U.S. Plasma Therapy Market, by Application
- Orthopedics
- Dermatology
- Hematology
- Neurology
- Immunology
- Dental
- Other Applications
- U.S. Plasma Therapy Market, by End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Other End-Users
- U.S. Plasma Therapy Market, by Type
- Canada
- Canada Plasma Therapy Market, by Type
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
- Hyperbaric Oxygen Therapy (HBOT)
- Combined Plasma Therapy with Stem Cells
- Other Types
- Canada Plasma Therapy Market, by Source
- Autologous
- Allogenic
- Canada Plasma Therapy Market, by Application
- Orthopedics
- Dermatology
- Hematology
- Neurology
- Immunology
- Dental
- Other Applications
- Canada Plasma Therapy Market, by End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Other End-Users
- Canada Plasma Therapy Market, by Type
-
Mexico
- Mexico Plasma Therapy Market, by Type
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
- Hyperbaric Oxygen Therapy (HBOT)
- Combined Plasma Therapy with Stem Cells
- Other Types
- Mexico Plasma Therapy Market, by Source
- Autologous
- Allogenic
- Mexico Plasma Therapy Market, by Application
- Orthopedics
- Dermatology
- Hematology
- Neurology
- Immunology
- Dental
- Other Applications
- Mexico Plasma Therapy Market, by End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Other End-Users
- Mexico Plasma Therapy Market, by Type
-
North America Plasma Therapy Market, by Type
- Europe
-
Europe Plasma Therapy Market, by Type
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
- Hyperbaric Oxygen Therapy (HBOT)
- Combined Plasma Therapy with Stem Cells
- Other Types
-
Europe Plasma Therapy Market, by Source
- Autologous
- Allogenic
-
Europe Plasma Therapy Market, by Application
- Orthopedics
- Dermatology
- Hematology
- Neurology
- Immunology
- Dental
- Other Applications
-
Europe Plasma Therapy Market, by End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Other End-Users
- U. K.
- U.K. Plasma Therapy Market, by Type
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
- Hyperbaric Oxygen Therapy (HBOT)
- Combined Plasma Therapy with Stem Cells
- Other Types
- U.K. Plasma Therapy Market, by Source
- Autologous
- Allogenic
- U.K. Plasma Therapy Market, by Application
- Orthopedics
- Dermatology
- Hematology
- Neurology
- Immunology
- Dental
- Other Applications
- U.K. Plasma Therapy Market, by End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Other End-Users
- U.K. Plasma Therapy Market, by Type
- France
- France Plasma Therapy Market, by Type
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
- Hyperbaric Oxygen Therapy (HBOT)
- Combined Plasma Therapy with Stem Cells
- Other Types
- France Plasma Therapy Market, by Source
- Autologous
- Allogenic
- France Plasma Therapy Market, by Application
- Orthopedics
- Dermatology
- Hematology
- Neurology
- Immunology
- Dental
- Other Applications
- France Plasma Therapy Market, by End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Other End-Users
- France Plasma Therapy Market, by Type
-
Germany
- Germany Plasma Therapy Market, by Type
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
- Hyperbaric Oxygen Therapy (HBOT)
- Combined Plasma Therapy with Stem Cells
- Other Types
- Germany Plasma Therapy Market, by Source
- Autologous
- Allogenic
- Germany Plasma Therapy Market, by Application
- Orthopedics
- Dermatology
- Hematology
- Neurology
- Immunology
- Dental
- Other Applications
- Germany Plasma Therapy Market, by End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Other End-Users
- Germany Plasma Therapy Market, by Type
-
Italy
- Italy Plasma Therapy Market, by Type
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
- Hyperbaric Oxygen Therapy (HBOT)
- Combined Plasma Therapy with Stem Cells
- Other Types
- Italy Plasma Therapy Market, by Source
- Autologous
- Allogenic
- Italy Plasma Therapy Market, by Application
- Orthopedics
- Dermatology
- Hematology
- Neurology
- Immunology
- Dental
- Other Applications
- Italy Plasma Therapy Market, by End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Other End-Users
- Italy Plasma Therapy Market, by Type
-
Spain
- Spain Plasma Therapy Market, by Type
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
- Hyperbaric Oxygen Therapy (HBOT)
- Combined Plasma Therapy with Stem Cells
- Other Types
- Spain Plasma Therapy Market, by Source
- Autologous
- Allogenic
- Spain Plasma Therapy Market, by Application
- Orthopedics
- Dermatology
- Hematology
- Neurology
- Immunology
- Dental
- Other Applications
- Spain Plasma Therapy Market, by End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Other End-Users
- Spain Plasma Therapy Market, by Type
-
Rest of Europe
- Rest of Europe Plasma Therapy Market, by Type
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
- Hyperbaric Oxygen Therapy (HBOT)
- Combined Plasma Therapy with Stem Cells
- Other Types
- Rest of Europe Plasma Therapy Market, by Source
- Autologous
- Allogenic
- Rest of Europe Plasma Therapy Market, by Application
- Orthopedics
- Dermatology
- Hematology
- Neurology
- Immunology
- Dental
- Other Applications
- Rest of Europe Plasma Therapy Market, by End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Other End-Users
- Rest of Europe Plasma Therapy Market, by Type
-
Europe Plasma Therapy Market, by Type
- Asia Pacific
-
Asia Pacific Plasma Therapy Market, by Type
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
- Hyperbaric Oxygen Therapy (HBOT)
- Combined Plasma Therapy with Stem Cells
- Other Types
-
Asia Pacific Plasma Therapy Market, by Source
- Autologous
- Allogenic
-
Asia Pacific Plasma Therapy Market, by Application
- Orthopedics
- Dermatology
- Hematology
- Neurology
- Immunology
- Dental
- Other Applications
-
Asia Pacific Plasma Therapy Market, by End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Other End-Users
- China
- China Plasma Therapy Market, by Type
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
- Hyperbaric Oxygen Therapy (HBOT)
- Combined Plasma Therapy with Stem Cells
- Other Types
- China Plasma Therapy Market, by Source
- Autologous
- Allogenic
- China Plasma Therapy Market, by Application
- Orthopedics
- Dermatology
- Hematology
- Neurology
- Immunology
- Dental
- Other Applications
- China Plasma Therapy Market, by End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Other End-Users
- China Plasma Therapy Market, by Type
- Japan
- Japan Plasma Therapy Market, by Type
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
- Hyperbaric Oxygen Therapy (HBOT)
- Combined Plasma Therapy with Stem Cells
- Other Types
- Japan Plasma Therapy Market, by Source
- Autologous
- Allogenic
- Japan Plasma Therapy Market, by Application
- Orthopedics
- Dermatology
- Hematology
- Neurology
- Immunology
- Dental
- Other Applications
- Japan Plasma Therapy Market, by End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Other End-Users
- Japan Plasma Therapy Market, by Type
-
Germany
- Germany Plasma Therapy Market, by Type
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
- Hyperbaric Oxygen Therapy (HBOT)
- Combined Plasma Therapy with Stem Cells
- Other Types
- Germany Plasma Therapy Market, by Source
- Autologous
- Allogenic
- Germany Plasma Therapy Market, by Application
- Orthopedics
- Dermatology
- Hematology
- Neurology
- Immunology
- Dental
- Other Applications
- Germany Plasma Therapy Market, by End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Other End-Users
- Germany Plasma Therapy Market, by Type
-
India
- India Plasma Therapy Market, by Type
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
- Hyperbaric Oxygen Therapy (HBOT)
- Combined Plasma Therapy with Stem Cells
- Other Types
- India Plasma Therapy Market, by Source
- Autologous
- Allogenic
- India Plasma Therapy Market, by Application
- Orthopedics
- Dermatology
- Hematology
- Neurology
- Immunology
- Dental
- Other Applications
- India Plasma Therapy Market, by End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Other End-Users
- India Plasma Therapy Market, by Type
-
South Korea
- South Korea Plasma Therapy Market, by Type
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
- Hyperbaric Oxygen Therapy (HBOT)
- Combined Plasma Therapy with Stem Cells
- Other Types
- South Korea Plasma Therapy Market, by Source
- Autologous
- Allogenic
- South Korea Plasma Therapy Market, by Application
- Orthopedics
- Dermatology
- Hematology
- Neurology
- Immunology
- Dental
- Other Applications
- South Korea Plasma Therapy Market, by End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Other End-Users
- South Korea Plasma Therapy Market, by Type
-
South East Asia
- South East Asia Plasma Therapy Market, by Type
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
- Hyperbaric Oxygen Therapy (HBOT)
- Combined Plasma Therapy with Stem Cells
- Other Types
- South East Asia Plasma Therapy Market, by Source
- Autologous
- Allogenic
- South East Asia Plasma Therapy Market, by Application
- Orthopedics
- Dermatology
- Hematology
- Neurology
- Immunology
- Dental
- Other Applications
- South East Asia Plasma Therapy Market, by End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Other End-Users
- South East Asia Plasma Therapy Market, by Type
-
Rest of Asia Pacific
- Rest of Asia Pacific Plasma Therapy Market, by Type
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
- Hyperbaric Oxygen Therapy (HBOT)
- Combined Plasma Therapy with Stem Cells
- Other Types
- Rest of Asia Pacific Plasma Therapy Market, by Source
- Autologous
- Allogenic
- Rest of Asia Pacific Plasma Therapy Market, by Application
- Orthopedics
- Dermatology
- Hematology
- Neurology
- Immunology
- Dental
- Other Applications
- Rest of Asia Pacific Plasma Therapy Market, by End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Other End-Users
- Rest of Asia Pacific Plasma Therapy Market, by Type
-
Asia Pacific Plasma Therapy Market, by Type
- Latin America
-
Latin America Plasma Therapy Market, by Type
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
- Hyperbaric Oxygen Therapy (HBOT)
- Combined Plasma Therapy with Stem Cells
- Other Types
-
Latin America Plasma Therapy Market, by Source
- Autologous
- Allogenic
-
Latin America Plasma Therapy Market, by Application
- Orthopedics
- Dermatology
- Hematology
- Neurology
- Immunology
- Dental
- Other Applications
-
Latin America Plasma Therapy Market, by End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Other End-Users
- Brazil
- Brazil Plasma Therapy Market, by Type
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
- Hyperbaric Oxygen Therapy (HBOT)
- Combined Plasma Therapy with Stem Cells
- Other Types
- Brazil Plasma Therapy Market, by Source
- Autologous
- Allogenic
- Brazil Plasma Therapy Market, by Application
- Orthopedics
- Dermatology
- Hematology
- Neurology
- Immunology
- Dental
- Other Applications
- Brazil Plasma Therapy Market, by End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Other End-Users
- Brazil Plasma Therapy Market, by Type
- Argentina
- Argentina Plasma Therapy Market, by Type
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
- Hyperbaric Oxygen Therapy (HBOT)
- Combined Plasma Therapy with Stem Cells
- Other Types
- Argentina Plasma Therapy Market, by Source
- Autologous
- Allogenic
- Argentina Plasma Therapy Market, by Application
- Orthopedics
- Dermatology
- Hematology
- Neurology
- Immunology
- Dental
- Other Applications
- Argentina Plasma Therapy Market, by End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Other End-Users
- Argentina Plasma Therapy Market, by Type
-
Rest of Latin America
- Rest of Latin America Plasma Therapy Market, by Type
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
- Hyperbaric Oxygen Therapy (HBOT)
- Combined Plasma Therapy with Stem Cells
- Other Types
- Rest of Latin America Plasma Therapy Market, by Source
- Autologous
- Allogenic
- Rest of Latin America Plasma Therapy Market, by Application
- Orthopedics
- Dermatology
- Hematology
- Neurology
- Immunology
- Dental
- Other Applications
- Rest of Latin America Plasma Therapy Market, by End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Other End-Users
- Rest of Latin America Plasma Therapy Market, by Type
-
Latin America Plasma Therapy Market, by Type
- Middle East & Africa
-
Middle East & Africa Plasma Therapy Market, by Type
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
- Hyperbaric Oxygen Therapy (HBOT)
- Combined Plasma Therapy with Stem Cells
- Other Types
-
Middle East & Africa Plasma Therapy Market, by Source
- Autologous
- Allogenic
-
Middle East & Africa Plasma Therapy Market, by Application
- Orthopedics
- Dermatology
- Hematology
- Neurology
- Immunology
- Dental
- Other Applications
-
Middle East & Africa Plasma Therapy Market, by End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Other End-Users
- GCC Countries
- GCC Countries Plasma Therapy Market, by Type
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
- Hyperbaric Oxygen Therapy (HBOT)
- Combined Plasma Therapy with Stem Cells
- Other Types
- GCC Countries Plasma Therapy Market, by Source
- Autologous
- Allogenic
- GCC Countries Plasma Therapy Market, by Application
- Orthopedics
- Dermatology
- Hematology
- Neurology
- Immunology
- Dental
- Other Applications
- GCC Countries Plasma Therapy Market, by End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Other End-Users
- GCC Countries Plasma Therapy Market, by Type
- South Africa
- South Africa Plasma Therapy Market, by Type
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
- Hyperbaric Oxygen Therapy (HBOT)
- Combined Plasma Therapy with Stem Cells
- Other Types
- South Africa Plasma Therapy Market, by Source
- Autologous
- Allogenic
- South Africa Plasma Therapy Market, by Application
- Orthopedics
- Dermatology
- Hematology
- Neurology
- Immunology
- Dental
- Other Applications
- South Africa Plasma Therapy Market, by End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Other End-Users
- South Africa Plasma Therapy Market, by Type
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Plasma Therapy Market, by Type
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
- Hyperbaric Oxygen Therapy (HBOT)
- Combined Plasma Therapy with Stem Cells
- Other Types
- Rest of Middle East & Africa Plasma Therapy Market, by Source
- Autologous
- Allogenic
- Rest of Middle East & Africa Plasma Therapy Market, by Application
- Orthopedics
- Dermatology
- Hematology
- Neurology
- Immunology
- Dental
- Other Applications
- Rest of Middle East & Africa Plasma Therapy Market, by End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Other End-Users
- Rest of Middle East & Africa Plasma Therapy Market, by Type
-
Middle East & Africa Plasma Therapy Market, by Type
- North America
FAQ
Frequently Asked Question
What is the global demand for Plasma Therapy in terms of revenue?
-
The global Plasma Therapy valued at USD 359.8 Billion in 2022 and is expected to reach USD 653.5 Billion in 2030 growing at a CAGR of 13.9%.
Which are the prominent players in the market?
-
The prominent players in the market are Cambryn Biologics LLC (U.S.), BioLife Plasma Services (U.S.), CSL Ltd. (Australia), Biotest Pharmaceuticals (Germany), Kedrion S.P.A. (Italy), Grifols International S.A. (Spain), China Biologic Products Inc. (China), LFB Plasma (U.S.), Octapharma Plasma Inc. (Switzerland).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 13.9% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Plasma Therapy include
- Rising Incidences of Sports Injuries
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Plasma Therapy in 2022.